[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100054080":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":13,"centralContacts":30,"locations":36,"responsibleParty":46,"collaborators":48,"id":52,"slug":7,"hasResults":53,"nctId":54,"briefTitle":55,"officialTitle":56,"acronym":57,"eligibilityCriteria":58,"healthyVolunteers":53,"sex":59,"minAge":60,"maxAge":7,"enrollmentInfo":61,"targetDuration":64,"studyType":65,"phases":7,"briefSummary":66,"conditions":67,"keywords":7,"overallStatus":39,"whyStopped":7,"lastUpdateSubmitDate":69,"lastUpdatePostDateStruct":70,"startDateStruct":73,"completionDateStruct":75,"leadSponsor":77,"locationsCount":78},{"fullName":5,"class":6},"iOMEDICO AG","INDUSTRY",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":7},"OTHER","Routine care as per site standard.","Physician's choice according to patient's needs.",[14,18,21,24,27],{"name":15,"affiliation":16,"role":17},"Hermann Einsele, Prof MD","Wuerzburg University Hospital","STUDY_CHAIR",{"name":19,"affiliation":20,"role":17},"Monika Engelhardt, Prof MD","Universitätsklinikum Freiburg",{"name":22,"affiliation":23,"role":17},"Tobias Dechow, Prof MD","Onkologie Ravensburg",{"name":25,"affiliation":26,"role":17},"Wolfgang Knauf, Prof MD","Centrum für Hämatologie und Onkologie Bethanien",{"name":28,"affiliation":29,"role":17},"Norbert Marschner, MD","Praxis für interdisziplinäre Onkologie & Hämatologie",[31],{"name":32,"role":33,"phone":34,"phoneExt":7,"email":35},"Martina Jänicke, PhD","CONTACT","+49 761 15242-0","info@iomedico.de",[37],{"facility":38,"status":39,"city":40,"state":7,"zip":7,"country":41,"cosmosGeoPoint":7,"geoPoint":7,"contacts":42},"Multiple sites all over germany","RECRUITING","Multiple Sites","Germany",[43],{"name":5,"role":33,"phone":44,"phoneExt":7,"email":45},"+49 761 152420","info@iomedico.com",{"type":47,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR",[49],{"name":50,"class":51},"Deutsche Studiengruppe Multiples Myelom (DSMM)","UNKNOWN","100054080",false,"NCT03308474","Myeloma Registry Platform (MYRIAM)","Clinical Research Platform for Molecular Testing, Treatment and Outcome of Patients With Multiple Myeloma (Myeloma Registry Platform; MYRIAM)","MYRIAM","Inclusion Criteria:\n\n* MM requiring systemic (first-, second- or third-line) treatment (closed for first-line \u002F second-line recruitment)\n* Age ≥ 18 years\n* Written informed consent\n\n  * Patients participating in the PRO satellite: signing of informed consent and completion of baseline questionnaire before, but not more than eight weeks before the start of respective systemic treatment\n  * Patients not participating in the PRO satellite: signing of informed consent not later than four weeks after start of respective treatment, and not more than eight weeks before the start of respective systemic treatment\n* Sufficient German language skills for participation in the PRO satellite\n\nExclusion Criteria:\n\n* No systemic therapy for myeloma\n* Patients already enrolled in studies that prohibit any participation in other studies","ALL","18 Years",{"count":62,"type":63},2200,"ESTIMATED","5 Years","OBSERVATIONAL","The purpose of the project is to set up a national, prospective, longitudinal, multicenter cohort study with associated satellites, a tumor registry platform, to document uniform data on characteristics, molecular diagnostics, treatment and course of disease, to collect patient-reported outcomes and to establish a decentralized biobank for patients with Multiple Myeloma in Germany.",[68],"Multiple Myeloma","2026-07-10",{"date":71,"type":72},"2026-07-13","ACTUAL",{"date":74,"type":72},"2017-09-25",{"date":76,"type":63},"2028-12",{"name":5,"class":6},1]